Genfit S.A. (EPA:GNFT)
France · Delayed Price · Currency is EUR 8.21
+0.01 (0.12%)
Apr 24, 2026, 3:24 PM CET
Genfit Employees
Genfit had 188 employees as of June 30, 2025.
Employees
188
Change
n/a
Growth
n/a
Revenue / Employee
€348,048
Profits / Employee
€457,277
Market Cap
408.32M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 188 | - | - |
| Dec 31, 2024 | 180 | 21 | 13.21% |
| Dec 31, 2023 | 159 | 11 | 7.43% |
| Dec 31, 2022 | 148 | 26 | 21.31% |
| Dec 31, 2021 | 122 | -8 | -6.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Cellectis | 229 |
| Innate Pharma | 174 |
| Transgene | 145 |
| MedinCell | 145 |
| DBV Technologies | 117 |
| Nanobiotix | 103 |
| Inventiva | 77 |
Genfit News
- 3 days ago - GENFIT: Publication of the 2026 Extra-Financial Report (fiscal year 2025) - GlobeNewsWire
- 21 days ago - GENFIT Reports Full-Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - GENFIT Receives FDA Orphan Drug Designation for NTZ for the treatment of ACLF - GlobeNewsWire
- 2 months ago - GENFIT to receive US$20M milestone after Ipsen's Iqirvo® exceeds the US$200M threshold in its first full year of net sales - GlobeNewsWire
- 3 months ago - GENFIT Announces 2026 Financial Calendar - GlobeNewsWire
- 4 months ago - GENFIT: GNS561 Shows Promising Antitumor Activity in Combination Therapy - GlobeNewsWire
- 5 months ago - GENFIT Announces Appointment of new Chief Medical Officer - GlobeNewsWire
- 5 months ago - GENFIT Reports Third Quarter 2025 Financial Information and Provides a Corporate Update - GlobeNewsWire